Drug-induced liver injury in obesity

Journal of Hepatology

Volumn 58, Issue 4, 2013, Pages 824-826

  Fromenty, Bernard ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INSERM   (France)

Author keywords

Cytochromes P450; DILI; Drug; Mitochondria; NAFLD; Obesity; Oxidative stress

Indexed keywords

APOLIPOPROTEIN B100; FATTY ACID; PENTOXIFYLLINE; ROSIGLITAZONE; TAMOXIFEN; VERY LOW DENSITY LIPOPROTEIN;

ACUTE HEPATITIS; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; HYPERINSULINEMIA; NONALCOHOLIC FATTY LIVER; NOTE; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; TOXIC HEPATITIS;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG-INDUCED LIVER INJURY; FATTY LIVER; GLUTATHIONE; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 84880945769     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.018     Document Type: Note

References (22)

1. B. Stuart, J. Lloyd, L. Zhao, and S. Kamal-Bahl Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries Curr Med Res Opin 24 2008 2377 2387
2. M. Porceddu, N. Buron, C. Roussel, G. Labbe, B. Fromenty, and A. Borgne-Sanchez Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria Toxicol Sci 129 2012 332 345
3. K. Begriche, J. Massart, M.A. Robin, A. Borgne-Sanchez, and B. Fromenty Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver J Hepatol 54 2011 773 794
4. J. Aubert, K. Begriche, L. Knockaert, M.A. Robin, and B. Fromenty Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role Clin Res Hepatol Gastroenterol 35 2011 630 637
5. G.C. Farrell Drugs and steatohepatitis Semin Liver Dis 22 2002 185 194 (Pubitemid 34496471)
6. M. Lemoine, L. Serfaty, and J. Capeau From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management Curr Opin Infect Dis 25 2012 10 16
7. S. Larrain, and M.E. Rinella A myriad of pathways to NASH Clin Liver Dis 16 2012 525 548
8. J. Massart, M.A. Robin, F. Noury, A. Fautrel, P. Lettéron, and A. Bado Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis Br J Pharmacol 165 2012 1361 1374
9. N.T. Gunaratnam, J. Benson, A.J. Gandolfi, and M. Chen Suspected isoflurane hepatitis in an obese patient with a history of halothane hepatitis Anesthesiology 83 1995 1361 1364
10. G.C. Nguyen, J. Sam, and P.J. Thuluvath Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis Hepatology 48 2008 1336 1341
11. G. Tarantino, P. Conca, V. Basile, A. Gentile, D. Capone, and G. Polichetti A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease Hepatol Res 37 2007 410 415 (Pubitemid 46915785)
12. Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013. .
13. P. Iozzo, M. Bucci, A. Roivainen, K. Någren, M.J. Järvisalo, and J. Kiss Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals Gastroenterology 139 2010 846 856
14. P. Lettéron, A. Sutton, A. Mansouri, B. Fromenty, and D. Pessayre Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice Hepatology 38 2003 133 140 (Pubitemid 36775804)
15. M.E. Visser, F. Akdim, D.L. Tribble, A.J. Nederveen, T.J. Kwoh, and J.J. Kastelein Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia J Lipid Res 51 2010 1057 1062
16. D. Pessayre, A. Mansouri, A. Berson, and B. Fromenty Mitochondrial involvement in drug-induced liver injury Handb Exp Pharmacol 196 2010 311 365
17. M.A. Robin, C. Demeilliers, A. Sutton, V. Paradis, C. Maisonneuve, and S. Dubois Alcohol increases tumor necrosis factor-α and decreases nuclear factor-κB to activate hepatic apoptosis in genetically obese mice Hepatology 42 2005 1280 1290 (Pubitemid 43260030)
18. R.J. Comi Drug-induced diabetes mellitus D. LeRoith, J. Olefsky, S. Taylor, Diabetes mellitus: a fundamental and clinical text 2004 Lippincott Williams & Wilkins Philadelphia, PA 880 886
19. M.J. Brill, J. Diepstraten, A. van Rongen, S. van Kralingen, J.N. van den Anker, and C.A. Knibbe Impact of obesity on drug metabolism and elimination in adults and children Clin Pharmacokinet 51 2012 277 304
20. J. Aubert, K. Begriche, M. Delannoy, I. Morel, J. Pajaud, and C. Ribault Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice J Pharmacol Exp Ther 342 2012 676 687
21. R.P. Myers, and A.A. Shaheen Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity Hepatology 49 2009 1399 1400
22. P. Forget, X. Wittebole, and P.F. Laterre Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases Br J Anaesth 103 2009 899 900